Low back pain (LBP) is a common presentation to the ED, and a frequent cause of disability globally. The ED management is often associated with high rates of imaging, misuse and overuse of pharmacology and subsequent financial implications. Given this, improved quality of care for patients with LBP in ED is essential. This rapid review investigated best practice for the assessment and management of LBP in the ED. PubMed, CINAHL, EMBASE, TRIP and the grey literature, including relevant organisational websites, were searched in 2015. Primary studies, systematic reviews and guidelines were considered for inclusion. English-language articles published in the past 10 years that addressed acute LBP assessment, management or prognosis in the ED or acute setting were included. Data extraction of included articles was conducted, followed by quality appraisal to rate the level of evidence where possible. The search revealed 1538 articles, of which 38 were included in the review (n = 8 primary articles, n = 13 systematic reviews and n = 17 guidelines). This rapid review provides clinicians managing LBP in the ED a summary of the best available evidence to risk stratify and enhance the quality of care, optimising patient outcomes. Consistent evidence was found to support the use of 'red flags' to screen for serious pathologies, diagnostic tests being reserved for use only in the presence of red flags, the judicious prescribing of opioids, identification of psychosocial risk factors as predictors of poorer outcome and promotion of early return to work and function.
Introduction
Low back pain (LBP) is the highest ranked cause of disability globally. 1 The most recent Australian data suggests one in seven Australians reported back pain in 2011-2012, and over two in five of these people reported limitations in activity due to their back problems. 2, 3 In Australia, healthcare expenditure due to LBP is also significant, estimated to total $1.2 billion in [2008] [2009] , not accounting for lost productivity. 4 In one Western Australian study, LBP accounted for 22 655 ED presentations (1.9% of total) between 2000 and 2004, with an average length of stay in ED of 4.4 h. 5 From these presentations, 43.8% were categorised as having 'muscular' LBP, and 17.1% of these patients were admitted with an average length of stay at 6.4 days. 5 More recent data from an Australian metropolitan hospital has reported higher prevalence, with 2.2% of all presentations in 2013 being due to LBP, and 32.2% of these patients being admitted. 6 Hospital admission accounts for significantly greater expenditure, 7, 8 estimated at 47.6% ($560 million) of the total healthcare expenditure on LBP. 4 This suggests LBP is a common complaint requiring a significant outlay of healthcare resources and continues to be a substantial source of disability in the wider population.
On presentation to the ED, the primary aim is to exclude serious pathology, which may require immediate intervention (such as fractures, malignancies, spinal cord or cauda equina compression). Thereafter, the ED management of LBP ideally focuses on controlling pain and restoring patient function. 9 This usually includes patient education, reassurance, advice and simple analgesics. 10 Patients with LBP often present to ED with high expectations of analgesia and investigations, which can make adhering to assessment and management guidelines challenging. 11 In addition, the National Emergency Access Target focuses on time-related outcomes, increasing the pressure to diagnose, manage and discharge patients rapidly, which may impact on the quality of care. 12, 13 Thus, despite clear management aims and the availability of clinical guidelines, the practical and environmental pressures of ED often lead to wide variations in care. 14, 15 It has been shown that compliance with evidence-based clinical guidelines for the management of patients with LBP can offer improvements in pain relief and patient satisfaction, and reduce the need for ongoing care. 16 In such guidelines, practitioners are strongly advised to limit the use of imaging 17, 18 and use a stepwise approach in prescribing analgesics. 19 Despite these guidelines, American data from the past decade indicates there has been a three-fold increase in the use of advanced imaging techniques (both magnetic resonance imaging and computed tomography, up to 11.3%), with stable use of radiographs (17%), and an increase in prescription opioid use (29.1%, up to 61% at discharge) in place of simple analgesics. 20, 21 In Australia, the available data also suggest high rates of imaging in ED, with radiography requested for 26.2% of patients and advanced imaging requested for 5.6% of patients. 6 These approaches offer no improvements to patient outcomes, increase exposure to the risks of opioid medications use and unnecessary radiation and lead to increases in the economic burden of LBP. 16, [22] [23] [24] There are multiple reasons why a patient may attend an ED rather than seeking general practitioner (GP) care. Reasons that are not specific to the LBP population include: reduced availability of and access to GPs; limited access to after-hours GP care; the gradual shift in GPs charging co-payments for consultations and the rise in ambulance utilisation where the ED is the universal destination point. Specific to the LBP patient population, they may also perceive a more urgent need for medical attention due to high levels of pain or inability to function. The ED may also be viewed as a 'onestop shop' that provides the relevant medications and diagnostics for their LBP, at no cost to the patient, whereas they are likely to incur these costs in the primary care setting. 25 For most patients with LBP, the condition is self-limiting, with rapid improvements in pain and function experienced in the first 6 weeks. 26, 27 However, in patients who seek treatment outside of the ED, high recurrence rates have been reported, 28 and nearly one-third may not have recovered at 12 months after their first presentation. 29 There is increasing emphasis on the role of psychosocial factors in identifying patients at risk of transitioning to chronic pain, but early screening and appropriate management of these risk factors is not routinely performed in the ED. 30 These patients, with a lack of resolution of symptoms, may also contribute to the large number of LBP presentations to the ED.
Given the burden of disease and financial impacts, high quality care of patients with LBP in the ED is essential. A rapid review was undertaken to identify the current best evidence for patients with acute LBP in the ED setting across the clinical cycle of care, including assessment, diagnostics, treatment and considerations for discharge and follow up. This rapid review forms part of a larger series, which is outlined in the corresponding methodology paper. 31 
Methods

Search strategy
A rapid review, which is a streamlined approach to synthesising evidence, was conducted in MarchApril 2015 of the past 10 years of scientific literature, including guidelines, primary articles and systematic reviews pertaining to quality care of LBP in the ED. The methodology for the review is outlined in more detail in the corresponding methodology paper.
31 Table 1 provides details of the literature search and selection process for this review.
Study selection and analysis
Primary studies, systematic reviews and guidelines were considered for inclusion. Articles were screened at title, abstract and full-text level by applying the inclusion/exclusion criteria. The National Health and Medical Research Council (NHMRC) levels of evidence hierarchy 32 was chosen to rate the levels of evidence as the scope of the review was quite broad, yielding articles utilising many different research designs (i.e. intervention, diagnosis, prognosis, aetiology and screening studies). Each primary article and systematic review was independently assigned a level of evidence by two members of the research team. Disagreement was resolved by reaching consensus and the research team was consulted if agreement could not be reached. All guidelines reported their own quality grading system within the guideline; therefore, insufficient information was available to be able to grade these articles against the NHMRC levels of evidence.
Of the primary studies, only Level II studies, as per the NHMRC levels of evidence hierarchy, were included (i.e. highest level of intervention, diagnostic accuracy and prognostic studies). Studies that were Level III-1 or lower were included in which safety and ethics concerns may have limited prospective research in that area, such as in the case of cauda equina. Systematic reviews of all evidence levels were included. Guidelines were included if the methodology for development was clearly documented.
Results
Search results
The initial search, following exclusion of duplicates and non-English articles, identified 1538 articles for screening ( Fig. 1) . At full text, eightprimary articles, [33] [34] [35] [36] [37] [38] [39] [40] 13 review articles 27,41-52 and 17 guidelines [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] were included.
Article characteristics and levels of evidence
Characteristics of the 38 included articles are shown in Tables 2-4 . The included articles ranged from Level I to IV evidence, with Level I being considered highest in the NHMRC hierarchy, based on the probability that the research designs at this level have minimised the impact of bias on the results. Of the primary articles, five were interventional randomised controlled trials providing Level II evidence, and the remaining three articles were retrospective chart reviews describing diagnostic accuracy and/or prognosis of Level II-IV evidence. These lower level studies were included to offer a comprehensive picture given the safety and ethical concerns with performing prospective research in some conditions. The systematic review articles included a mix of Level II interventions (n = 4), Level III-2 interventions (n = 1), Level II diagnostic accuracy (n = 4), Level II combined intervention and diagnostic accuracy (n = 1), Level II prognosis (n = 2) and a Level II qualitative review (n = 1). All included guidelines were based on literature review and expert consensus, but varied in formatting and use of critical appraisal tools.
Evidence across the clinical cycle of care in the ED
The included articles covered many aspects of the clinical cycle of care for the ED management of LBP, and the major findings and recommendations have been summarised in Figure 2 . The findings from each included article have been synthesised into different aspects of the clinical cycle and are presented in Appendix S2.
Initial assessment
There is evidence to support screening for 'red flags' to exclude serious pathologies. The specific conditions and 'red flag' signs varied between articles and are listed in Figure 2 . This recommendation is supported by primary articles (n = 1 article of Level II evidence, n = 2 articles of Level III-2 evidence), systematic reviews (n = 6 articles of Level II evidence) and guidelines (n = 8). The importance of identifying psychosocial risk factors, known as 'yellow flags', was recommended in systematic reviews (n = 2 articles of Level II evidence) and guidelines (n = 6), reflecting the suggested value of this information in predicting those at risk of a poor prognosis.
Imaging and diagnostic tests
Evidence supporting the selection, or non-selection, of imaging was covered in systematic reviews (n = 3 articles of Level II evidence), and guidelines (n = 11). It was consistently concluded that imaging should only be used in the case of trauma or when red flags were present in the assessment. Specific recommendations for each imaging modality are presented in Figure 2 . Pathology tests were not routinely recommended in the management of LBP, but should be reserved for the role of excluding serious conditions. This was supported by evidence in a systematic review (n = 1 article of Level II evidence) and guidelines (n = 4).
Treatment
Several articles addressed the importance of differentiating LBP between different diagnoses: the majority of LBP as those that have no pathoanatomical cause, those that are associated with radiculopathy or spinal stenosis and the minority of cases whose pain is caused by a serious condition with a specific diagnosis. This evidence was reflected in systematic reviews (n = 3 articles of Level II evidence) and guidelines (n = 5). The diagnosis and severity of symptoms should then guide the management, where the judicious use of analgesia, particularly opioids, was supported by evidence in primary articles (n = 4 articles of Level II evidence), systematic reviews (n = 2 articles of Level II evidence) and guidelines (n = 8). It was recommended that the management of LBP in ED also include nonpharmacological strategies such as targeted education and reassurance, cold or heat and exercise recommendations. These were evidenced in a primary article (n = 1 article of Level II evidence), systematic reviews (n = 2 articles of Level II evidence) and guidelines (n = 8).
Referrals and follow up
Follow up was considered in systematic reviews (n = 4 articles of Level II evidence, n = 1 article of Level III-2 evidence) and guidelines (n = 8), which broadly included GP, surgical, specialist and allied health referrals. Early follow up for patients with identified 'yellow flags' was recommended in a systematic review (n = 1 article of Level II evidence) and guidelines (n = 4). For those patients with a chronic history or persistent pain, guidelines (n = 4) indicated community health involvement or referral to a multidisciplinary pain management team. It was suggested in guidelines (n = 5) that an early return to work, even if on modified duties, should be encouraged to promote better patient outcomes.
Discussion
This rapid review identified several key points integral to providing quality care for musculoskeletal patients within the ED. Broadly, this includes the exclusion of sinister pathologies, identification of psychosocial risk factors for poor prognosis, imaging only in the presence of 'red flags', first-line use of simple analgesics, judicious use of shortacting opioid analgesics in severe pain (if at all), education to regain function and increase general exercise, encouraging GP follow up and promoting early return to work in some capacity. Some of these key points, such as excluding sinister pathology, may already be common practice in many EDs. However, other key points such as psychosocial screening, judicious use of imaging and opioid analgesics and early return to work or activity promotion, may represent areas where inconsistencies in care exist.
Medical imaging and other diagnostic tests
Articles reviewed consistently recommended avoiding routine imaging in patients with acute LBP. In line with this, the recent 'Choosing Wisely Australia' campaign made the 
GP:
Patients should be encouraged to follow-up with their GP for non-specific LBP and non-serious conditions. Specialist: Recommended in the presence of serious pathology or red flags.
• Patients with 'yellow flags' 46, 56, 57, 60, 63 Physiotherapy: Those patients unlikely to improve with aforementioned pain relief strategies may benefit from ongoing non-pharmacological treatments with a Physiotherapist.
• May benefit from early referral to psychology if psychosocial risk factors are present.
• Also consider referral to physiotherapy or other allied health.
Chronic LBP 56, 63, 65, 68 • Return to Work 57, 60, 63, 65, 69 Refer for community health involvement or referral to a multidisciplinary pain management team.
• An early return to work, even if on modified duties, promotes better outcomes for patients and is associated with less disability.
•
Neurological signs:
Screen and assess for 'red flags' 35, 38, 40, 41, 43-45, 49, 52, 54, 56, 57, 60, 62-65, 69 • • bilateral numbness or weakness in the lower limbs, gait disturbance or ataxia.
• loss of bladder/bowel function (urinary retention, incontinence, absent anal sphincter tone, patulous anus, reduced/absent bulbocavernosus reflex), sexual dysfunction, saddle anaesthesia.
unilateral multiple nerve root distribution of numbness and weakness.
• •
History of trauma with any focal spinal tenderness on palpation, contusion or abrasion, altered consciousness or distracting injury. Medication effects (i.e. corticosteroid or anticoagulant use).
Risk factors or signs of infection, systemic disease or malignancy: persistent fever, night sweats, rash, abnormal laboratory exams, intravenous drug use, recent bacterial infection, immunocompromised, history of malignancy or unexplained weight loss, nocturnal pain, <20 years and >50 years of age, non-mechanical pain.
Persistent or intractable pain not responding to appropriate treatment.
• Identify 'yellow flags' 46, 49, 56, 57, 59, 63, 65, 68 • E.g. past history of LBP, fear of re-injury, depression / history of mental health issues, social and emotional stresses, low job satisfaction.
• Imaging only indicated in trauma or red flags 41, 46, 49, 54, 56-58, 60-63, 66, 67, 69 X-ray indicated in suspected vertebral compression fracture.
• MRI indicated in presence of neurological abnormalities or suspected malignancy.
CT indicated in known high-velocity trauma, poor visualization of vertebral fracture on x-ray, or if MRI contraindicated. • do not provide a definitive cause for initial episodes of LBP.
• consider grouping patients into either non-specific LBP, back pain potentially with associated radiculopathy or spinal stenosis, or back pain potentially associated with another specific spinal cause.
Pain relief is an important aspect of ED management of LBP
• Pharmacological management 33, 34, 36, 37, 41, 50, 55-58, 60, 63-65, 69 • First-line analgesics should include paracetamol or ibuprofen (with consideration of their side-effect profiles in relation to the patient and their adequacy in relieving pain).
• • Non-pharmacological management 39, 41, 49, 56, 57, 59, 60, [63] [64] [65] 69 Avoid the use of opioids unless in some cases with severe pain; if prescribed, short-acting doses, for a limited duration, with consideration of the risk for misuse and abuse.
• • Heat and/or cold packs, according to availability and patient preference.
Education and reassurance: good prognosis, avoid bed rest, advice for "self care", stay active and continue with normal activities; return to ED if 'red flags' arise. following statement, 'Don't perform imaging for patients with non-specific acute low back pain and no indicators of a serious cause for low back pain'. 17 Convincing evidence to support this recommendation includes the inconsistent correlation between findings on imaging and patientreported symptoms, 70 the lack of association with improved outcomes 22 and the poorer subjective sense of well-being reported by patients who receive imaging. 71 Furthermore, in the absence of neurological deficits, suspected malignancy, infection or trauma, imaging is not necessary for effective management 56, 72 and it may increase the likelihood of unnecessary surgery and inefficacious costly interventions. 73 One reviewed article recommended a number of pathology tests; 53 however, it should be noted that these are only indicated to exclude red flags, and it should not be included in the routine investigation and management of LBP in ED. It is likely that the overuse of imaging and pathology testing is driven by the pressure to exclude serious pathology, to make an accurate diagnosis and to fulfil patient expectations. Although understandable, the benefits of avoiding unnecessary diagnostic testing are clear, and clinicians must be encouraged to comply with evidence-based practice.
Opioids
The prescription of opioids is currently very topical due to the dramatic increase in use, the significant variation in opioid-prescribing patterns in ED, the increase in opioidrelated harms such as hospitalisations and deaths due to accidental poisoning and the corresponding costs to the Australian government. 74, 75 Analysis of opioid-prescribing patterns in EDs suggest an increase in the use of opioids in place of simple analgesics, 20, 74 an increasing trend of opioids prescribing on discharge from EDs 21 and significant variations between clinicians in prescribing opioids specifically for LBP in ED. 76 The evidence in this rapid review clearly supports a reduction in the use of opioids, with some articles recommending reserving opioid use for severe pain, or recommended against opioid use due to questionable efficacy and increased adverse events. 50, [55] [56] [57] 60, [63] [64] [65] Although early prescription of opioids in this setting may reduce pain severity more rapidly, research shows that this is associated with longer term opioid use, increased costs and increased risk of adverse events. 23 For this reason, opioid prescription in ED must be reserved for the most severe cases of LBP, where simple analgesics have been insufficient.
Psychosocial factors
In the past few decades, psychosocial factors known as 'yellow flags' have emerged as the most important consideration to identify those at risk of developing chronic pain. 77, 78 This view was supported by the reviewed articles, which promoted psychosocial screening during assessment. Disappointingly, there was little suggestion of what action should be taken when these factors are identified in the acute setting and some might argue that as these factors do not pose an immediate threat to well-being, they are not a priority for management in the ED. It is acknowledged that ED clinicians are often under significant time pressure, and psychosocial factors can be complex and can take some time to properly assess and understand. However, given the known personal, societal and economic burden of chronic LBP 1 and the potential for early intervention to reduce this burden, [77] [78] [79] proactive strategies should be encouraged in the ED.
In the absence of clear evidence for the management of 'yellow flags' in the ED, the authors recommend that clinicians make use of readily available, quick, easy and reliable psychosocial screening tools, such as the Örebro Musculoskeletal Pain Screening Questionnaire 80 or the STarT Back Tool, 79 to identify patients at high risk for a poor recovery and to aid in the initial decision making for referrals and follow up. While in the ED, high-risk patients should be given appropriate reassurance, education on simple self-management strategies and encouragement to resume normal activity. These patients should then be referred on for early psychological intervention and/or active physiotherapy management where possible, 77, 78 coordinated with their regular GP.
Early return to work
Evidence from the rapid review supports that an early return to work for patients with LBP, even if on modified duties, promotes better outcomes for patients and is associated with less disability. Careful consideration should be made to the issuing of medical certificates, as there is evidence to suggest that medical certificates recommending a complete absence from work creates major challenges later in terms of return to work, labour force productivity, the viability of the compensation system and long-term social and economic development. 81 Although it may not be the ED's responsibility to ensure that systems exist in the work place to facilitate a return to work, it is the ED's role to refer patients appropriately for early co-ordinated care in the community so that a return to work plan is enacted and extended leave is avoided. 82 Evidence suggests there is significant variability in duration of work absence in people with LBP who eventually do return to work, ranging from 5-61 days, which further highlights the importance of early community follow up in order to capture the higher risk patients. 83 It is also essential to commence patient education on return to work options and outline the health consequences of remaining off work, which include the adverse impacts on mental and physical health, high social and economic costs and possible permanent work disability.
Limitations
As described in the corresponding methodology paper, 31 there are limitations with conducting a rapid review. Strict inclusion and exclusion criteria were used in order to curtail the duration of the review process, which may have introduced the risk of bias; however, the limitations in this instance also serve to provide the best and most recent evidence. For this rapid review on LBP, primary articles of a lower level of evidence were included when the topic was related to red flag conditions in which prospective methodology would be both unsafe and unethical. Similarly, while systematic database searches were undertaken, a systematic and exhaustive handsearch was not, which may mean that some relevant articles were not included.
Conclusion
This rapid review serves to provide a summary of the most recent and highest quality evidence supporting best practice for the assessment, use of diagnostic testing, pharmacological and non-pharmacological management and discharge considerations and advice for patients who present to ED with LBP. There is abundant and strong evidence supporting the exclusion of serious pathology by screening for 'red flags', more targeted use of imaging and pharmacological management, the identification of psychosocial risk factors from 'yellow flags' with associated appropriate discharge planning and promoting an early return to work and functioning following the ED visit. LBP is a common presentation to all EDs and clinicians should aim to adhere to the evidence base and best practice management presented in this review in order to improve patient outcomes and utilise resources more effectively.
